-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
February 01, 2013 - future health status of
people with respect to burden of the disease and health outcomes: mortality,
morbidity
-
hcup-us.ahrq.gov/db/nation/nass/stats/NASS_Summary_Stats_DX_PR_GRPS_Weighted_2022.pdf
January 01, 2022 - External Causes 9097088 0 0 1.000000 0.153216 0.001719 1896888 36713
DXCCSR_EXTnnn External Causes of Morbidity
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2021.pdf
January 01, 2021 - 8,896,507 0 0 1 1,972,901 36,719.19 1,900,902.13 2,044,900.48
22 DXCCSR_EXTnnn External Causes of Morbidity
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2021.pdf
January 01, 2021 - DX_PR_GRPS File
Variable / Label
N
N
Miss Minimum Maximum Mean Sum
DXCCSR_EXTnnn : External Causes of Morbidity
-
hcup-us.ahrq.gov/reports/methods/2004CCSUserGuideFinal.pdf
September 01, 2004 - Morbidity and Mortality Weekly Report, 1997, Aug 29; 46(no.
RR14): 1-30.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - Insufficient
QOL EORTC QLQ-C30
& LC 13 V3.0
instruments
Treatment toxicity Incidence of
Grade ≥II RTOG
morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_executive.pdf
May 01, 2011 - Trends in Asthma
Morbidity and Mortality. American Lung Association.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - Morbidity during hospitalization: can we
predict it?
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/VpT-c4bnmvHFRPyKgPwb2Z
December 01, 2010 - KQ 2b: Are there positive outcomes other than reduced falls, and related morbidity and mortality, that
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hDZUZdx4qLNc2PjbkfWQuw
April 01, 2016 - We considered preferences, or utilities, to account
for morbidity from screening and treatment.
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2020.pdf
January 01, 2020 - Variable Label N NMiss Min Max Sum StdErrorSum LowerCLSum UpperCLSum
21 DXCCSR_EXTnnn External Causes of Morbidity
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2020.pdf
January 01, 2020 - Other Consequences of External Causes 7,828,310 0 0 1 0.2 1,328,383
DXCCSR_EXTnnn : External Causes of Morbidity
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2019.pdf
January 01, 2019 - Variable Label N NMiss Min Max Sum StdErrorSum LowerCLSum UpperCLSum
21 DXCCSR_EXTnnn External Causes of Morbidity
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2019.pdf
January 01, 2019 - Other Consequences of External Causes 8,994,101 0 0 1 0.2 1,450,824
DXCCSR_EXTnnn : External Causes of Morbidity
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
March 15, 2005 - Long-term morbidity is common among infants with both encephalitis and disseminated disease, and may
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
March 01, 2005 - Long-
term morbidity is common among infants with both
encephalitis and disseminated disease, and may
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
February 02, 2012 - ECI-4 screening of at-
tention deficit-hyperactivity disorder and
co-morbidity in Mexican preschool
children
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
February 02, 2012 - ECI-4 screening of at
tention deficit-hyperactivity disorder and
co-morbidity in Mexican preschool
-
www.ahrq.gov/sites/default/files/2025-02/raab-report.pdf
January 01, 2025 - Patient harm was classified on an interval scale representing levels of
morbidity to mortality.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
December 31, 2022 - :15/177 (8%)
Age (<70 or >70 years), sex,
presence of respiratory symptoms,
peak CRP levels, co-morbidities